Pharming Group (PHAR) News Today $8.95 0.00 (0.00%) Closing price 02/21/2025 03:57 PM EasternExtended Trading$8.95 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Pharming Group (NASDAQ:PHAR) Shares Gap Up - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Up - What's Next?February 21 at 12:12 PM | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest Down 68.4% in JanuaryPharming Group (NASDAQ:PHAR - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 7,500 shares, a drop of 68.4% from the January 15th total of 23,700 shares. Based on an average daily volume of 7,200 shares, the days-to-cover ratio is presently 1.0 days.February 12, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Still a Buy?February 11, 2025 | marketbeat.comHigh Growth Tech And These 3 Dynamic Stocks with Promising ExpansionFebruary 11, 2025 | finance.yahoo.comPharming Completes Acquisition of Abliva SharesFebruary 7, 2025 | tipranks.comPharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance periodFebruary 7, 2025 | globenewswire.comPharming Group (NASDAQ:PHAR) Trading 5.7% Higher - Here's WhyPharming Group (NASDAQ:PHAR) Trading Up 5.7% - Here's What HappenedFebruary 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Here's WhyPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Should You Buy?February 5, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading Down 7.8% - Time to Sell?Pharming Group (NASDAQ:PHAR) Trading Down 7.8% - Should You Sell?February 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - Still a Buy?Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Time to Buy?January 29, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Up 5.4% - Should You Buy?Pharming Group (NASDAQ:PHAR) Stock Price Up 5.4% - Should You Buy?January 28, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Should You Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?January 24, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - What's Next?January 22, 2025 | marketbeat.comPharming to nominate Fabrice Chouraqui as new CEO, succeeding Sijmen de VriesJanuary 21, 2025 | markets.businessinsider.comPharming Group Announces EGM for Leadership TransitionJanuary 21, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhyPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedJanuary 21, 2025 | marketbeat.comPharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEOJanuary 21, 2025 | msn.comPharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive OfficerJanuary 21, 2025 | markets.businessinsider.comPharming Group Nominates Fabrice Chouraqui as New CEOJanuary 21, 2025 | tipranks.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Should You Sell?Pharming Group (NASDAQ:PHAR) Shares Gap Down - What's Next?January 15, 2025 | marketbeat.comShort Interest in Pharming Group (NASDAQ:PHAR) Grows By 149.0%Pharming Group (NASDAQ:PHAR - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 25,900 shares, an increase of 149.0% from the December 15th total of 10,400 shares. Based on an average trading volume of 6,700 shares, the days-to-cover ratio is currently 3.9 days.January 14, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Down 3.4% - Time to Sell?Pharming Group (NASDAQ:PHAR) Stock Price Down 3.4% - What's Next?January 6, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's What HappenedPharming Group (NASDAQ:PHAR) Shares Gap Down - Here's WhyJanuary 3, 2025 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading 6.1% Higher - What's Next?Pharming Group (NASDAQ:PHAR) Trading 6.1% Higher - Still a Buy?December 31, 2024 | marketbeat.comShort Interest in Pharming Group (NASDAQ:PHAR) Decreases By 48.8%Pharming Group (NASDAQ:PHAR - Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 10,400 shares, a decrease of 48.8% from the November 30th total of 20,300 shares. Based on an average daily volume of 7,400 shares, the short-interest ratio is presently 1.4 days.December 27, 2024 | marketbeat.com3 Promising Penny Stocks With At Least US$80M Market CapDecember 25, 2024 | uk.finance.yahoo.comPharming Group (NASDAQ:PHAR) Trading Down 3.9% - Here's WhyPharming Group (NASDAQ:PHAR) Shares Down 3.9% - What's Next?December 24, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Trading 6.6% Higher - Should You Buy?Pharming Group (NASDAQ:PHAR) Stock Price Up 6.6% - Should You Buy?December 23, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Shares Gap Up - Still a Buy?Pharming Group (NASDAQ:PHAR) Shares Gap Up - Time to Buy?December 19, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Pharming Group (NASDAQ:PHAR)HC Wainwright reaffirmed a "buy" rating and set a $37.00 price objective on shares of Pharming Group in a research report on Tuesday.December 17, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)December 17, 2024 | markets.businessinsider.comPharming Group offers to buy Sweden's Abliva for SEK 0.45/shrDecember 16, 2024 | seekingalpha.comPharming Group Offers To Acquire Abliva For SEK 0.45/shr In CashDecember 16, 2024 | markets.businessinsider.comPharming announces public cash offer to the shareholders of Abliva ABDecember 15, 2024 | markets.businessinsider.comRBC Capital Remains a Buy on Pharming Group (PHGUF)December 13, 2024 | markets.businessinsider.comPharming announces positive topline data in pediatric clinical trial of leniolisibDecember 11, 2024 | markets.businessinsider.comEuropean Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder DrugDecember 11, 2024 | benzinga.comPharming Group (NASDAQ:PHAR) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $37.00 price objective on shares of Pharming Group in a report on Wednesday.December 11, 2024 | marketbeat.comPharming Group’s Pediatric Trial Yields Positive ResultsDecember 11, 2024 | tipranks.comPharming initiated with a Buy at JefferiesDecember 9, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Pharming Group N.V. - Depositary Receipt () (PHAR) with Buy RecommendationDecember 9, 2024 | msn.comJefferies Initiates Coverage of Pharming Group N.V. - Depositary Receipt () (PHAR) with Buy RecommendationDecember 9, 2024 | msn.comCritical Insights From Pharming Analyst Ratings: What You Need To KnowDecember 9, 2024 | benzinga.comCritical Insights From Pharming Analyst Ratings: What You Need To KnowDecember 9, 2024 | benzinga.comJefferies Financial Group Initiates Coverage on Pharming Group (NASDAQ:PHAR)Jefferies Financial Group initiated coverage on Pharming Group in a report on Monday. They set a "buy" rating and a $14.00 price target on the stock.December 9, 2024 | marketbeat.comPharming Group (NASDAQ:PHAR) Short Interest UpdatePharming Group (NASDAQ:PHAR - Get Free Report) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 25,500 shares, an increase of 165.6% from the October 31st total of 9,600 shares. Based on an average trading volume of 6,600 shares, the days-to-cover ratio is currently 3.9 days.November 28, 2024 | marketbeat.comPharming Group And 2 Other Promising Penny Stocks To WatchNovember 26, 2024 | finance.yahoo.comEncore Healthcare: Pharming the FutureNovember 11, 2024 | msn.comPharming Group N.V. (PHARM.AS)November 8, 2024 | finance.yahoo.comPharming Group to participate in November investor conferenceNovember 5, 2024 | finance.yahoo.com Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PHAR Media Mentions By Week PHAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHAR News Sentiment▼1.110.60▲Average Medical News Sentiment PHAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHAR Articles This Week▼12▲PHAR Articles Average Week Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HCM News Today EWTX News Today MIRM News Today AMRX News Today KYMR News Today GMTX News Today PTGX News Today MESO News Today CNTA News Today BHC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHAR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHAR Stock Alerts